APA (7th ed.) Citation

Taylor, D. N., Treanor, J. J., Sheldon, E. A., Johnson, C., Umlauf, S., Song, L., . . . Shaw, A. (2012). Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response. Vaccine, 30(39), 5761-5769. https://doi.org/10.1016/j.vaccine.2012.06.086

Chicago Style (17th ed.) Citation

Taylor, David N., et al. "Development of VAX128, a Recombinant Hemagglutinin (HA) Influenza-flagellin Fusion Vaccine with Improved Safety and Immune Response." Vaccine 30, no. 39 (2012): 5761-5769. https://doi.org/10.1016/j.vaccine.2012.06.086.

MLA (9th ed.) Citation

Taylor, David N., et al. "Development of VAX128, a Recombinant Hemagglutinin (HA) Influenza-flagellin Fusion Vaccine with Improved Safety and Immune Response." Vaccine, vol. 30, no. 39, 2012, pp. 5761-5769, https://doi.org/10.1016/j.vaccine.2012.06.086.